Save time and get answers to complex questions with AI chat
Adefovir dipivoxil discount cardIs liver function monitoring necessary with lipitorEnhertu loss of exclusivity patent expirationOzempic jordan price 2026Nicardipine brand names
See the DrugPatentWatch profile for Orphenadrine
I’m not aware of a publicly‑released “official” price tag for producing a single dose of orphenadrine (the active ingredient in Norflex®), and companies typically keep that data confidential. However, it’s possible to sketch out the major cost drivers that go into making the drug and to give a very rough idea of where the dollar bill might land in a large‑scale, GMP‑compliant operation.
Key take‑aways
Scale matters a lot – the more tablets you run in a single batch, the lower the per‑tablet cost because fixed overheads (GMP, QA/QC, equipment amortization) are spread across more units.
Route selection – Orphenadrine is usually produced via a two‑step synthesis from diphenylmethylamine: an alkylation step followed by a dehydrochlorination. If a company has an in‑house synthesis, it can reduce outsourcing costs. However, proprietary routes that improve yields or reduce impurities can also increase upfront R&D and licensing costs.
Regulatory environment – GMP‑grade manufacturing in the EU or U.S. incurs higher costs than non‑GMP production (used for research labs or “in‑house” processes). These costs are reflected in the overhead line.
Raw‑material price volatility – Commodity chemicals (like anilines or chlorinated intermediates) can fluctuate seasonally or due to geopolitical events, so the cost can vary by a few cents per tablet year‑to‑year.
Packaging choices – Some manufacturers use low‑cost blister packs while others may opt for pre‑filled syringes or specialized blister cards, which can shift the cost upward.
If you need a deeper dive into a specific manufacturing route or help with a cost‑analysis spreadsheet, let me know!
Other Questions About Orphenadrine :